SN
Senzime AB (publ)
SNZZF · OTC
$0.35 +0.00% (+$0.00)
1M -12.73%
Market Cap 525.8M kr
P/E Ratio -
Div. Yield -
ROE 37.22%
Piotroski F-Score Weak
3/9Valuation
61 /100
Fair P/S 5.13x
P/B 1.99x
P/E N/A
Growth
89 /100
Growing Rev. growth 94.81%
Book val. growth 5.06%
EPS growth N/A
Profitability
12 /100
Weak Gross margin 32.11%
Net margin 108.94%
FCF margin 94.21%
Quality
4 /100
Poor ROIC 36.94%
ROE 37.22%
Asset turnover 0.31x
Debt
69 /100
Low Debt/Equity 0.09x
Current ratio 3.31x
Int. coverage -24.49x
Stability
43 /100
Moderate Beta 0.40x
Rev. volatility 49.15%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SNZZF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Philip Siberg
Employees
58
Headquarters
Uppsala
Nadcházející události
29 ŘÍJ
Earnings
Upcoming earnings report